Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis

Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate Sponsors:   Tanta University;   Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;   Fedaa Abd El-monem Kamal El-deen Kotkata Faculty of Pharmacy, Tanta University;   Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials